Brief: 3Sbio Says Application For Launch Of 5% Minoxidil Foam Submitted To NMPA Of PRC Was Accepted
11/01/2022 13:33
Jan 11 (Reuters) - 3SBio Inc 1530.HK :
* APPLICATION FOR MARKET LAUNCH OF 5% MINOXIDIL FOAM
SUBMITTED TO
NMPA OF PRC WAS ACCEPTED FOR TREATMENT OF ANDROGENETIC ALOPECIA
Further company coverage: 1530.HK
((Reuters.Briefs@thomsonreuters.com;))